Factors associated with the loss of response to infliximab in patients with Crohn’s disease
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy
Reference37 articles.
1. ACCENT I study group. Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial;Hanauer;Lancet,2002
2. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial;Hanauer;Gastroenterology,2006
3. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005
4. Review article: infliximab therapy for inflammatory bowel disease — seven years on;Rutgeerts;Aliment Pharmacol Ther,2006
5. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease;Baert;N Engl J Med,2003
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Simultaneous quantification and structural characterization of monoclonal antibodies after administration using capillary zone electrophoresis-tandem mass spectrometry;Journal of Pharmaceutical and Biomedical Analysis;2023-09
2. Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy;World Journal of Gastroenterology;2022-09-14
3. Systematic review: efficacy of escalated maintenance anti‐tumour necrosis factor therapy in Crohn's disease;Alimentary Pharmacology & Therapeutics;2021-06-21
4. The role of adipose tissue in the pathogenesis of Crohn’s disease;Pharmacological Reports;2019-02
5. Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series;Cytokine;2018-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3